Results 171 to 180 of about 374,223 (267)

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Long-term protection from naturally acquired immunity against hepatitis E virus reinfection. [PDF]

Nat Commun
Liu X, Zang X, Zhu K, Huang X, Hu X, Bi Z, Chen Q, Jiang H, Wang Y, Yang C, Liu D, Zhu W, Zheng Z, Su Y, Wu T, Huang S, Zhuang C, Zhang J, Xia N.   +18 more
europepmc   +1 more source

A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses [PDF]

Roxanne Fouillé, Éloi R. Verrier, Amse De Meyer, Lieven Verhoye, Maud Michelet, Romain Barnault, Caroline Pons, Olivier Diaz, Michel Rivoire, Guillaume Passot, Eike Steinmann, Heiner Wedemeyer, Anna Salvetti, Nicole Pavio, Virginie Doceul, Raphaël Darteil, Philip Meuleman, David Durantel, Julie Lucifora   +18 more
openalex   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

A Rare Case of Triple Infection with Leptospira, Hepatitis A Virus, and Hepatitis E Virus. [PDF]

Reports (MDPI)
Petrakis V, Babaka N, Panopoulou M, Papazoglou D, Panagopoulos P.   +4 more
europepmc   +1 more source

Modeling and comprehensive strategic intervention analysis for Hepatitis A and E infections: A paradigm shift in public health dynamics

Adedapo Chris Loyinmi
openalex   +2 more sources

A New Era for Using Natural Pigments: The Case of the C50 Carotenoid Called Bacterioruberin

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Haloarchaea are extremophilic microorganisms belonging to the Archaea domain that require high salt concentrations to live, thus inhabiting ecosystems like salty ponds, salty marshes, or extremely salty lagoons. They are more abundant and widely distributed worldwide than initially expected.
Micaela Giani, Elena Valdés, José María Miralles‐Robledillo, Guillermo Martínez, Carmen Pire, Rosa María Martínez‐Espinosa   +5 more
wiley   +1 more source

Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium. [PDF]

Liver Int
Buchardt L, Thi VLD, Johne R, Ziersch M, Harms D, Hofmann J, Dinkelborg K, Klöhn M, Choi M, Kurreck J, Wedemeyer H, Todt D.   +11 more
europepmc   +1 more source

Transient Transfection of Rolling‐Circle Amplified DNA in Biomanufacturing‐Relevant Mammalian Cell Lines: A Comparison of Transfection Conditions for Optimal Protein Expression

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Rolling‐circle amplification (RCA) is a completely synthetic and rapid mechanism for scaling‐up bulk DNA that eliminates requirements for large‐scale bacterial fermentation. Several reports have described the surprising ability of large unprocessed (hyperbranched) rolling circle‐amplified DNA (RCA DNA) to effectively transfect cultured cells ...
Evelina Loghin, Erik Kvam, Lisa Lowery, Nathan Hudson, Jenny Keen, Brian Davis, Roger B. Dodd, Christine Surrette, John Nelson   +8 more
wiley   +1 more source

Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection. [PDF]

Liver Int
Schemmerer M, Pflüger LS, Schneider T, Lu J, Kienle K, Meyer-Schlinkmann KM, Mühlbacher A, Polz J, Schennach H, Xie Q, Voitenleitner C, Wenzel J, Lütgehetmann M.   +12 more
europepmc   +1 more source